GlassScriptPhysician profile
Neil D Parikh
NPI 1417199316
$68,204.92
in general payments reported to CMS, 2019-2025
44 companies · $31K in 2025
The $31K reported for 2025 was more than what 96% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,368 · 2020: $224 · 2021: $191 · 2022: $1,804 · 2023: $4,247 · 2024: $30K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Consulting Fee: $21K · Food and Beverage: $9,268 · Travel and Lodging: $4,279 · Education: $33.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,375.00 |
| Consulting Fee | $20,663.00 |
| Food and Beverage | $9,267.88 |
| Travel and Lodging | $4,279.41 |
| Education | $33.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $25,918.08 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $10,450.26 | 2019-2025 | Trulance, Xifaxan |
| Iterative Scopes, INC. | $6,600.00 | 2024 | Skout |
| Medtronic, INC. | $5,693.63 | 2024-2025 | Gi Genius, Endoflip, Nexpowder |
| Boston Scientific Corporation | $4,916.24 | 2023-2024 | Axios |
| Takeda Pharmaceuticals U.S.A., INC. | $3,022.21 | 2019-2025 | Eohilia, Entyvio, Gattex |
| Olympus America INC. | $2,200.00 | 2025 | Gastrointestinal Videoscope, Evis Exera III Colonovideoscope |
| Abbvie INC. | $1,800.40 | 2019-2025 | |
| Lucid Diagnostics INC. | $1,388.72 | 2023-2025 | |
| Janssen Biotech, INC. | $1,059.29 | 2019-2025 | Stelara, Tremfya, Simponi Aria |
| Mahana Therapeutics, INC. | $824.60 | 2022 | |
| Genzyme Corporation | $435.13 | 2022-2025 | |
| Pfizer INC. | $430.91 | 2019-2025 | |
| Celgene Corporation | $347.03 | 2021-2024 | Zeposia |
| Qol Medical, LLC | $291.40 | 2019-2025 | Sucraid, Sucraid |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $278.17 | 2022-2025 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $268.97 | 2019-2024 | Linzess |
| Madrigal Pharmaceuticals | $248.58 | 2024-2025 | Rezdiffra, Resmetirom |
| Blueprint Medicines Corporation | $192.41 | 2023-2024 | Ayvakit |
| Ferring Pharmaceuticals INC. | $167.27 | 2019-2024 | Rebyota |
| Exact Sciences Corporation | $163.48 | 2023-2025 | Cologuard Collection Kit |
| Evoke Pharma, INC. | $160.34 | 2023-2024 | Gimoti |
| Regeneron Healthcare Solutions, INC. | $150.58 | 2022-2025 | Dupixent |
| Aimmune Therapeutics, INC. | $148.59 | 2024-2025 | Zenpep |
| Lilly USA, LLC | $147.15 | 2025 | Omvoh |
| Allergan, INC. | $129.65 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $120.27 | 2023 | |
| Gilead Sciences, INC. | $103.02 | 2019-2025 | |
| Intercept Pharmaceuticals, INC. | $82.20 | 2023-2025 | Ocaliva |
| Fujifilm Healthcare Americas Corporation | $61.17 | 2022-2023 | Fujifilm |
| Braintree Laboratories, INC. | $55.19 | 2023-2025 | Sutab, Suflave |
| Fresenius Kabi USA, LLC | $53.06 | 2023 | Idacio |
| Shire North American Group INC | $48.99 | 2019 | |
| Janssen Scientific Affairs, LLC | $41.36 | 2023 | Stelara |
| Polynovo North America LLC | $37.89 | 2025 | Novosorb Btm |
| Novo Nordisk INC | $34.23 | 2025 | Wegovy |
| Amgen INC. | $25.14 | 2022 | |
| Glaxosmithkline, LLC. | $21.62 | 2022 | |
| Ucb, INC. | $20.76 | 2019 | |
| Celltrion USA INC. | $17.09 | 2024 | Zymfentra |
| Amag Pharmaceuticals, INC. | $17.04 | 2020 | |
| Daiichi Sankyo INC. | $16.66 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.14 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$38,879.76 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.